◦muscle and body pain
◦changes in your liver function tests
Additional side effects that have been reported in people taking LIPTRUZET, ezetimibe or atorvastatin in clinical studies or general use include: joint pain; diarrhea; tendon problems; memory loss; confusion; depression.

Tell your doctor if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of LIPTRUZET. For more information, ask your doctor or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store LIPTRUZET?

◦Store LIPTRUZET at room temperature between 68°F to 77°F (20°C to 25°C).
◦Keep LIPTRUZET in the foil pouch until you are ready to take it.
◦After you remove a LIPTRUZET tablet from the blister card, slide the blister card back into the case (where a case is provided) and store in a dry place.
◦Write down the date the foil pouch was opened in the space provided.
◦Keep LIPTRUZET tablets dry and out of the light.
◦Safely throw away unused LIPTRUZET tablets 30 days after the foil pouch is opened.
Keep LIPTRUZET and all medicines out of the reach of children.

General information about the safe and effective use of LIPTRUZET.

LIPTRUZET may help to reduce your cholesterol in 2 ways. It reduces the cholesterol absorbed in your digestive tract, as well as the cholesterol your body makes by itself. LIPTRUZET does not help you lose weight.

Medicines are sometimes prescribed for purposes other than those listed in the Patient Information leaflet. Do not use LIPTRUZET for a condition for which it was not prescribed. Do not give LIPTRUZET to other people, even if they have the same problem that you have. It may harm them.

This Patient Information leaflet summarizes the most important information about LIPTRUZET. If you would like more information, talk with your doctor. You can ask your pharmacist or doctor for information about LIPTRUZET that is written for health professionals.

For more information, go to www.LIPTRUZET.com or call 1-800-672-6372.

What are the ingredients in LIPTRUZET?

Active ingredients: ezetimibe and atorvastatin

Inactive ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate, lactose anhydrous, hydroxypropyl cellulose, sodium bicarbonate. The tablet film coating contains the following inactive ingredients: hydroxypropyl cellulose, hypromellose, titanium dioxide, and carnauba wax

This Patient Information has been approved by the U.S. Food and Drug Administration

Manufactured by:

Merck Sharp & Dohme Corp., a subsidiary of
MERCK & CO., INC., Whitehouse Station, NJ 08889, USA

U.S. Patent Nos. 5,846,966 and RE37,721.

Issued: 05/2013

USPPI-T-0653C1305R000

PRINCIPAL DISPLAY PANEL -- 10 mg/10 mg Tablet Carton

This carton
contains
3 patient pouches.

Each pouch
contains 10 tablets.

NDC 66582-320-30

Liptruzet ™
(ezetimibe and atorvastatin) tablets

10 mg/10 mg

Do not open pouch until you are ready to use LIPTRUZET.
After the foil pouch is opened, protect LIPTRUZET from
moisture and